Skip to main content
KNSA
NASDAQ Life Sciences

Kiniksa Posts Q3 EPS of 56 Cents

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$74.99
Mkt Cap
$5.694B
52W Low
$35.2
52W High
$84.06
52W Position info
113% above low
Off High info
11% below high
Rel. Volume info
2.5× avg
Market data snapshot near publication time

KNSA has more than doubled off its 52-week low of $35.2 on elevated volume (2.5× avg).

Summary

Kiniksa reported third-quarter earnings per share of 56 cents, per Dow Jones Newswires, with net income of $47.3M and revenue of $286M. That follows a strong second quarter in which ARCALYST revenue hit $243.6M, up 55% year over year, and management raised full-year guidance to $980–$995M. The stock trades near $75 with a roughly $5.7B market cap, so a profitable quarter at this level is consistent with the growth story rather than a surprise reset. Watch for ARCALYST revenue and whether the $980–$995M guidance range holds or moves.

At the time of this announcement, KNSA was trading at $74.99 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.7B. The 52-week trading range was $35.20 to $84.06. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

KNSA - Latest Insights

KNSA
Jul 28, 2026, 4:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $79.95
Real-time Price: $84.27 info
Change: +$4.32 (+5%) info
Market Cap: $5.694B info
KNSA
Jul 28, 2026, 7:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $63.30
Real-time Price: $84.27 info
Change: +$20.97 (+33%) info
Market Cap: $5.694B info
KNSA
Jul 28, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $63.30
Real-time Price: $84.27 info
Change: +$20.97 (+33%) info
Market Cap: $5.694B info
KNSA
Jun 02, 2026, 4:50 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $46.70
Real-time Price: $84.27 info
Change: +$37.57 (+80%) info
Market Cap: $5.694B info
KNSA
May 26, 2026, 5:04 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $52.86
Real-time Price: $84.27 info
Change: +$31.41 (+59%) info
Market Cap: $5.694B info